FDG PET/CT to predict pathologic complete response to neoadjuvant systemic treatment in breast and axilla in triple negative and in HER2-positive breast cancer

  • M. Van Ramshorst
  • , S. Teixeira
  • , K. Pengel
  • , K. Gilhuijs
  • , R. Valdes Olmos
  • , S. Rodenhuis
  • , E. Rutgers
  • , W. Vogel
  • , G. Sonke
  • , M. J. Vrancken Peeters

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S95-S96
JournalEuropean Journal of Cancer
Volume57
Publication statusPublished - Apr 2016

Cite this